AbsTrACT
Objective cardiac catheterisation and implantable cardioverter defibrillator (icD) insertion are increasingly common following cardiac arrest survival. however, much of the evidence for the benefit is observational, leaving open the possibility that biased patient selection confounds the association between these invasive procedures and improved outcome. We evaluated the likelihood of selection bias in the association between cardiac catheterisation or icD placement and outcome by measuring long-term outcomes overall and in a causespecific approach that separated cardiac mortality from non-cardiac mortality. Methods We performed a multivariable survival analysis of a clinical cohort between 2005 and 2013, with follow-up through 2015. We included patients who had out-of-hospital or inhospital cardiac arrest that survived to discharge, and evaluated the association between cardiac catheterisation or icD insertion and all-cause, cardiovascular and noncardiovascular mortality. results among 678 patients who survived cardiac arrest, we observed lower all-cause mortality among patients who underwent cardiac catheterisation (adjusted hr (ahr) 0.40; P<0.01) or icD insertion (ahr 0.55; P<0.01). however, cause-specific analysis showed that the benefits of cardiac catheterisation and icD insertion resulted from reduced non-cardiac causes of death (cardiac catheterisation: ahr 0.24, P<0.01; icD: ahr 0.58, P<0.01), while reduced cardiac cause of death was not associated with cardiac catheterisation (cardiac catheterisation: ahr 0.75, P=0.33). Conclusions there is evidence of selection bias in the secondary prevention survival benefit attributable to cardiac catheterisation for patients who survive cardiac arrest. Observational studies that consider its effects on all-cause mortality likely overestimate the potential benefit of this procedure.
InTrOduCTIOn
Urgent or emergent cardiac catheterisation is associated with improved survival after cardiac arrest, 1 2 including among patients with non-ST elevation myocardial infarction or non-shockable initial rhythms. [3] [4] [5] Consequently, the 2015 American Heart Association Guidelines for postarrest management recommend that cardiac catheterisation is reasonable regardless of presenting rhythm or persistence of postarrest coma. 2 Together, these observational data and recommendations are likely responsible for the increasing frequency of this procedure in postcardiac arrest management. 6 Rates of implantable cardioverter defibrillator (ICD) insertion after cardiac arrest are also increasing, 7 8 similarly based on anticipated reductions in cardiac mortality through secondary prevention. [9] [10] [11] [12] [13] However, most of the evidence for the benefit of coronary angiography is observational, leaving open the possibility that patient selection confounds the association between these invasive procedures and outcome (figure 1).
We examined long-term mortality in a cohort of cardiac arrest survivors to determine whether there was evidence of bias in the selection of patients for cardiac catheterisation or ICD insertion. We evaluated long-term outcomes overall and in a cause-specific approach that separated cardiac and non-cardiac mortality.
MeThOds
We performed our analysis using a detailed prospective clinical registry of cardiac arrest survivors, linked to three large administrative databases.
Clinical registry: Post-cardiac Arrest service
The University of Pittsburgh has a dedicated Post-Cardiac Arrest Service (PCAS) that provides care for an increasing number of postarrest patients, now in excess of 300 patients annually, of which approximately 30% survive to discharge. Details of the care we provide across the spectrum of prehospital, intensive care unit, acute hospitalisation and postacute rehabilitation have been previously described in detail. 5 As part of our quality improvement and research missions, we maintain a prospective registry of postarrest patients treated at seven hospitals in Southwestern Pennsylvania. This registry includes standard demographic information (age, sex, race, presenting rhythm, arrest location (out-of-hospital vs in-hospital)), details of care during the index hospitalisation including performance of cardiac catheterisation or ICD insertion and outcomes at hospital discharge including survival, the modified Rankin score and cerebral performance category (CPC). 14 15 We performed a manual chart review of all cases where cardiac catheterisation was recorded and documented if an intervention (ie, percutaneous intraluminal stenting or coronary artery bypass grafting) was performed. We carried out this step to provide additional information on the emergent coronary revascularisation practice in our system. We included patients cared for in the hospital after cardiac arrest from 2005 to 2013 and survived to hospital discharge. We limited the analysis to these patients, as it was our objective to evaluate the potential secondary prevention benefits of cardiac catheterisation and ICD insertion. We excluded subjects where cardiac arrest occurred secondary to trauma or acute surgical or neurological catastrophe. We further excluded patients who already had an ICD in place prior to the index hospitalisation.
Long-term outcome assessment: national death Index
The National Death Index (NDI) is a vital statistics system maintained by the National Center for Health Statistics, a component of the National Vital Statistics System, in the Centers for Disease Control and Prevention. The National Center for Health Statistics employs a variety of data collection methods that compile the NDI, which is based on state vital statistics office death reports. The NDI is used extensively for identifying deaths in the USA [16] [17] [18] [19] [20] [21] [22] and has modest accuracy for identifying cardiac causes. 23 We obtained these records to identify long-term outcomes and cause of death for patients in the PCAS registry, and linked records as previously described. 5 We categorised causes of death into nine categories (cardiac, infection, malignancy, respiratory, central nervous system, renal, accident or trauma, diabetes or other) and then into two categories (cardiac and non-cardiac). We considered cardiac causes of death to be the following: acute myocardial infarction, including cardiac arrest (I21-I22), all other forms of chronic ischaemic heart disease (I20, I25.1-I25.9), all other forms of heart disease (I26-I28, I34-I38, I42-I49, I51), aortic aneurysm and dissection (I71), atherosclerosis (I70), atherosclerotic cardiovascular disease, so described (I25.0), essential (primary) hypertension and hypertensive renal disease (I10, I12), heart failure (I50), hypertensive heart disease (I11) and other disorders of circulatory system (I80-I99). All other causes of death were considered non-cardiac.
Comorbidities and outpatient procedures: Pennsylvania health care Cost Containment Council
The Pennsylvania Health care Cost Containment Council (PHC4) is an independent state agency responsible for maintaining a state-wide all payer records of clinical encounters for the purposes of healthcare quality improvement. We obtained PHC4 records for all inpatient and outpatient procedures from 2005 to 2015. We obtained these records for three reasons: (1) identify cardiac catheterisation and ICD insertions occurring after index hospitalisation, to avoid exposure misclassification; (2) verify and update comorbid medical conditions for patients included in the PCAS registry, to improve the accuracy of the clinical information; and (3) identify International Classification of Diseases (ICD) procedure codes that occurred prior to the index cardiac arrest hospitalisation, to validate patient PCAS ICD status. We used social security number, date of birth and name to link PCAS registry records to the PHC4 data. We included records through the end of 2015 to include 2 years of PHC4 follow-up on the PCAS registry.
hospital characteristics: hospital Cost report Information system and MedPAr
We obtained hospital characteristics (number of hospital beds, number intensive care unit beds, hospital teaching statuscategorising hospitals as non-teaching if they had no resident trainees, small teaching if the ratio was more than 0 and less than 0.2 and large teaching if the ratio was 0.2 or greater), 24 using the Hospital Cost Report Information System (HCRIS) information, a database maintained by the Centers for Medicare and Medicaid. We categorised hospitals according to the volume of procedures for cardiac catheterisation (using ICD-9P codes 37.22, 37.23, 88.53, 88.54, 00.66, 36.04, 36.06 and 36.07) and volume of ICD insertion (using ICD-9P codes 00.50, 00.51, 37.94-37.96, and 37.80-37.83) using the 2010 Medicare Provider Analysis and Review (MedPAR) file, the final action claim of all hospitalised fee-for-service Medicare beneficiaries. MedPAR is the only national source of hospital claims data and is used extensively for research purposes. We used a threshold of 160 percutaneous coronary interventions 25 and 55 implantable coronary interventions 26 to consider a centre 'high volume' for each procedure, which we based on prior volume-outcome thresholds. We also categorised hospitals according to the volume of admissions for cardiac arrest (using ICD-9 code 42.75), categorising hospitals as high volume if they had more than 50 admissions per year in MedPAR. 27 We adjusted these thresholds to account for the age profile of patients included in Medicare.
Figure 1
Selection bias example. In a cohort of cardiac arrest survivors (A), some patients had cardiac catheterisation during their hospitalisation (B) and others did not (C). Overall, patients who had cardiac catheterisation experienced a lower hazard of death (B vs C). However, when separated by cause of death, cardiac catheterisation was associated with a reduction in non-cardiovascular causes of death (D), rather than a decrease in cardiovascular causes of death (E). This association suggests the presence of at least a component of selection bias in the observed relationship between cardiac catheterisation and improved patient outcomes.
Arrhythmias and sudden death Analysis
We summarised patient demographics, clinical characteristics, interventions, follow-up, outcomes and hospital characteristics using descriptive statistics. We described continuous variables with medians and interquartile ranges and categorical variables with frequencies and percentages. We performed an overall description of the cohort and causes of death, and additionally described the cohort when stratified by cardiac catheterisation exposure. For the stratified description, we performed comparisons of frequencies and medians using χ 2 and ranked-sum tests, as appropriate. We performed multivariable Cox proportional hazards analyses for all-cause, cardiac-case and non-cardiac cause of death. These models controlled for age, sex, race, shockable rhythm, favourable CPC score, location of cardiac arrest and hospital-level volume of cardiac arrest. We selected these variables a priori to control for sources of confounding based on our prior analyses reporting significant predictors of long-term survival after cardiac arrest. 5 For the continuous variables age and Charlson Index, we used a locally weighted scatterplot smoothing (lowess) plot against mortality to identify category breakpoints. We performed this step to generate results that were more easily interpreted. We used a hierarchical modelling approach that accounted for clustering postestimation at the hospital level. We evaluated statistical significance at the alpha 0.05 level.
As recommendations for cardiac catheterisation differ following cardiac arrests in the outpatient and inpatient settings, we additionally performed our primary analysis in arrest location stratified cohorts. Although our primary analysis controlled for the location of cardiac arrest, the stratified analysis would directly produce separate measures of association, facilitating interpretation. We applied the same modelling approach and significance testing as in the primary Cox proportional hazards analysis.
Analysis was performed using STATA V.13.1.
resuLTs
We identified 907 patients who were admitted to the hospital and survived to discharge after sustaining cardiac arrest between 2005 and 2013. We excluded 223 cases where the patient already had an ICD in place and additional six cases where patients were admitted to hospitals that did not perform ICD placement, leaving a final cohort of 678 patients. All records were successfully linked to records from PHC4 and HCRIS. Slightly more than one-third of patients had a cardiac catheterisation (n=231, 34.1%) and one-eighth had an ICD insertion (n=86, 12.7%) performed during the index hospitalisation (table 1) . We reclassified cardiac catheterisation in one patient (0.1%) who had an outpatient cardiac catheterisation 3 months after discharge from the index hospitalisation and one patient (0.1%) who had an ICD placed 3 months after discharge from the index hospitalisation. Hospitals ranged from medium to very large in numbers of total beds and intensive care unit beds (online supplementary table 3). All hospitals performed cardiac catheterisation and 80% (n=4) performed a high annual volume of cardiac catheterisation. Similarly, all hospitals performed ICD insertion and 80% (n=4) performed a high annual volume of ICD insertion (the same hospital was low volume for both cardiac catheterisation and ICD insertion). Eighty percent of hospitals reported a high number of cardiac arrest cases (the low volume hospital for cardiac arrest had high procedural volume for cardiac catheterisation and ICD insertion).
One-third of deaths were from cardiac causes (n=89; 34% ; table 2 and online supplementary table 4 ). The main non-cardiac causes of death were attributed to infection (n=25; 10%), malignancy (n=24; 9%) and respiratory diseases (n=24; 9%). No causes of death were reported as unknown.
Using Cox proportional hazards regression predicting all-cause mortality, increasing age and Charlson Comorbidity Index were associated with increased hazard of death, while female sex, out-of-hospital cardiac arrest, favourable discharge CPC, cardiac catheterisation, ICD insertion and high hospital volume of cardiac arrests were associated with decreased hazard of death (P<0.05 for all associations; table 3). In a model predicting cardiac cause of death, increasing age and Charlson Comorbidity Index were associated with increased hazard of death, while female sex, initial shockable rhythm, favourable CPC, ICD insertion and high hospital volume of cardiac arrests were associated with decreased hazard of death (P<0.05 for all associations; table 4). Cardiac catheterisation was not associated with lower hazard of death (cardiac catheterisation: 0.75, P=0.33). In a model predicting non-cardiac cause of death, increasing age, black race, other race and highest Charlson Comorbidity Index category were associated with increased hazard of death. In the same model, out-of-hospital cardiac arrest, favourable CPC 
dIsCussIOn
Using a detailed clinical registry linked to several complementary administrative databases, we identified that selection bias contributes to the observed associations between cardiac catheterisation or ICD insertion and reduced mortality among patients discharged alive after cardiac arrest. We observed a strong protective effect for both procedures when considering all-cause mortality. However, in our cause-specific analysis, Table 2 Causes of death among deceased people in National Death Index (n=265)
Cause Count
Cardiac diseases, n (%) 89 (34) Infection, n (%) 25 (9) Malignancy, n (%) 24 (9) Respiratory diseases, n (%) 24 (9) Central nervous system diseases, n (%) 14 (5) Renal failure, n (%) 13 (5) Accident or trauma, n (%) 11 (4) Diabetes, n (%) 10 (4) Other causes, n (%) 55 (21) Arrhythmias and sudden death cardiac catheterisation was not associated with a reduction in cardiac death, while both procedures were associated with reduced hazards of non-cardiac deaths. The expected findings for secondary benefit from these procedures would be lower rates of cardiac deaths and slightly higher rates of non-cardiac deaths (due to a lower competing cause of death from cardiac deaths) in the intervention cohort. There is no clear mechanism for improved non-cardiac mortality following cardiac catheterisation or ICD insertion. These findings suggest that catheterisation and ICD insertion were performed on patients who already had better anticipated postarrest prognosis. Many univariate characteristics and comorbidities differed between the group of patients who had cardiac catheterisation and those who did not-supporting the notion that the groups differed in important ways. We performed several checks on our data. We searched a state-wide database to identify cases of cardiac catheterisation or ICD insertion that occurred after discharge, to avoid exposure misclassification (we identified two events, and reclassified both patient exposures). It might have been clinically appropriate, for example, to discharge select patients with a wearable defibrillator as a bridge to myocardial recovery or eventual ICD insertion, or to defer diagnostic coronary angiography until outpatient follow-up. These patients would be expected to still derive a long-term survival benefit from exposure to these procedures, even if they were performed after the index hospitalisation. Furthermore, to ensure that patients had an opportunity for exposure (in this case, a procedure), we limited our cohort inclusion to hospitals that performed both procedures, and in fact, 80% of the hospitals performed them at a high annual volume. We only studied patients who survived the index hospital discharge, minimising selection bias due to moribund postarrest clinical status. Our observed overall mortality was consistent with recent estimates in another large cohort. 28 Finally, we performed a manual chart review of all recorded cardiac catheterisations to describe the frequency of coronary interventions. We intentionally did not evaluate coronary angiography with an intervention as an exposure, as it was our interest to evaluate a strategy, and the results of the procedure cannot be known in advance of performing it.
Our analysis has several limitations. We used NDI data to determine cause of death, which likely resulted in some outcome misclassification due to classification inaccuracies. However, in this cohort outcome misclassification would be expected to be non-differential, with errors made in both directions-as supported in a recent review of NDI coding accuracy for cardiac cause of death. 23 The effect of non-differential outcome misclassification is to bias a result towards the null. While this would therefore not affect the validity of our non-cardiac outcome observation, outcome misspecification could have affected our cardiac outcome null finding. Even still, a non-null finding for cardiac outcomes would not have changed the collective interpretation of the results. Although the rate of angiography in our cohort was 34% (which is similar to other cardiac arrest cohorts and higher than the 19.2% catheterisation rate reported in a very large out-of-hospital cardiac arrest cohort 29 ) , it was lower than systems that may employ a more aggressive strategy with regard to cardiac catheterisation. 30 Despite a rate lower than some systems, we still feel our use of angiography reflects acceptable contemporary practice, and therefore supports the generalisability of the results. Although we were successfully able to identify outpatient procedures, we did not have access to outpatient clinic records. However, clinic visitation would have been difficult to interpret regardless, as a patient may improve their health status through clinic visitation, or clinic visitation may be a marker of declining health. We selected a cohort of patients who survived to discharge, making them potentially different from patients who obtain return of spontaneous circulation, patients who survive 24 hours after cardiac arrest or patients at other intermediate time points. We do not feel this diminishes the results, but it is important to note that the population who survives to discharge is, by selection, a subpopulation of all patients who have a cardiac arrest. Finally, we did not have information on the extent of preserved ejection fraction among survivors, which would have allowed us to estimate expected rates of ICD insertion.
Our findings suggest that the observed benefit of cardiac catheterisation in survivors of cardiac arrest is in part the result of patient selection bias. While there may be real secondary prevention benefits from both procedures, the magnitude of effect is likely smaller than reports from observational research. Randomised-controlled trials are important to evaluate these interventions and additionally should be powered to detect a smaller effect size than reported in the literature.
Key messages
What is already known on this subject? Cardiac catheterisation appears to confer a mortality benefit in patients who survive cardiac arrest; however, the evidence is observational and subject to sources of bias.
What might this study add?
This study shows that at least some of the reported outcome benefit from cardiac catheterisation in patients who survive cardiac arrest is produced by patient selection.
how might this impact on clinical practice?
While there may be real outcome benefits from cardiac catheterisation in this patient group, the magnitude of benefit is likely smaller than reported in observational studies. This has implications for both research purposes (where a magnitude of benefit will drive sample size determinations) and clinical practice.
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